Or both explanations could be true. We can’t be sure from the studies whether that’s the case – but good sense would state it’s quite likely to end up being both. The evidence displays though that whether these women have abortions – or continue to provide birth – their threat of having mental health issues will not increase. They carry approximately equal risks. We believe this is actually the most comprehensive and detailed overview of the mental health outcomes of abortion to date world-wide. Dr Roch Cantwell, a consultant perinatal psychiatrist who chaired the steering group, stated the review was needed in 2008. Most of us recognize abortion is an extremely emotive and sensitive topic.This research will evaluate ALKS 3831's effects and security on metabolic outcomes, including weight gain, in individuals with schizophrenia. Additional studies will investigate ALKS 3831 for the large numbers of individuals with the dual analysis of schizophrenia and substance abuse, a group representing as much as 50 percent of patients with schizophrenia. Elliot Ehrich, M.D., Chief Medical Officer of Alkermes commented, We believe that the addition of the opioid modulating properties of ALKS 33 to olanzapine creates the chance for a broader spectrum schizophrenia treatment that could be a useful therapeutic choice for physicians and patients in two important ways.